Drug utilization pattern in acute coronary syndrome at tertiary care hospital: a prospective cross-sectional observational study
Keywords:Acute coronary syndrome, Drug utilization
Background: To study the pattern of utilization of drug in the patients of Acute Coronary Syndrome at tertiary care hospital.
Methods: Prospective cross-sectional observational drug utilization study was conducted in patients of acute coronary syndrome admitted in ICCU, for the period of two months. Data was collected in preformed Case record form. Analysis was done by using drug use indicators, demographic pattern, morbidity pattern of disease, pattern of drug use. Data analysed using Microsoft Excel SPSS software - version 21.l. Total 71 cases were analysed.
Results: In our study we analysed 71 patients out of that 50 were male and 21 were female patients. The mean age of patient was 57.61±11.09 yr; most belonging to age group of 51-60 years (36.62%). Number of patients undergoing thrombolysis were 28(39.43%) and 43(60.57%) underwent percutaneous coronary intervention (PCI). Total 44 different drugs were used and 565 drugs were prescribed in 71 patients. Most frequently prescribed drugs were Clopidogrel and aspirin in 100% encounters, followed by atorvastatin (85%).Average number of drugs per encounter was 7.96. Percentage of drugs prescribed by generic name was 16.28%.
Conclusions: The present study provides valuable insight about the overall pattern of drug used in Acute Coronary syndrome. Physician should be encouraged to prescribe drugs with generic name.
Deaton C, Froelicher ES, Shishani K, Jaarsma T. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs. 2011;10(2):5-13.
Fuster V, Kelly BB. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries. Washington (DC): National Academies Press (US). 2010.
Fuster V. Global Buren of Cardiovascular disease. J Am Coll Cardiol. 2014;64(5):520-2.
Abbas S, Kitchlew AR, Abbas S. Disease Burden of Ischemic Heart Disease in Pakistan and its Risk Factors. Ann. Pak. Inst. Med. Sci. 2009;5(3):145-50.
Cannon CP, Braunwald E. Non-ST-Segment elevation Acute Coronary Syndrome (Non-ST-Segment Elevatin Myocardial Infarction and Unstable Angina. In: Kalper DL, Hauser SL, Jameson JL, eds. Harrison’s Principles of Internal Medicines.19th ed. New York, NY: McGraw-Hill. 2015:1593-98.
Scottish Intercollegiate Guidelines Network, Acute coronary syndromes, a national clinical guideline. 2007:5.
Braunwald E, Antman EM, Beasley JW. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: 2002: summary article: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation. 2002;106(14):1893-900.
Antman EM, Anbe DT, Armstrong PW. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction-Executive Summary: a report of the ACC/AHA Task Force on Practice Guidelines. Circulation. 2004;110(5):588-636.
Ghosh A, Das AK, Pramanik S, Saha UK. Drug utilization study in patients of acute coronary syndrome on follow-up visits at a tertiary care center in Kolkata. Asian Journal of Pharmacy and Life Science. 2012;2(2):155-65.
Fahimi F, Baniasadi S, Behzadnia N, Varahram F Tabatabaie LG. Enoxaparin Utilization Evaluation: An Observational Prospective Study in Medical Inpatients Iranian Journal of Pharmaceutical Research. 2008;7(1):77-82.
Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in North India. Hindawi Publishing Corporation, Emergency Medicine International. 2014;1-5.
Patel BJ, Patel KH, Trivedi HR. Drug Utilization Study In Intensive Coronary Care Unit of A Tertiary Care Teaching Hospital. NJIRM. 2012;3(4):28-33.
Christian RP, Rana DA, Malhotra SD, Patel VJ. Evaluation of rationality in prescribing, adherence to treatment guidelines, and direct cost of treatment in intensive cardiac care unit: A prospective observational study. Indian J Crit Care Med. 2014;1(18):278-84.
Sandozi T, Nausheen F. Drug utilization study in ischemic heart diseases associated with Diabetes and hypertension. IJBPS. 2010;1(3):1-4.
Isezuo S. Characteristics, treatment and one-year outcomes of patients with acute coronary syndrome in a tertiary hospital in India. Indian Heart Journal. 2014;6:156-63.
Xavier D, Pais PP, Devereaux PJ. On behalf of the CREATE registry investigators. Treatment and outcomes of acutecoronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371:1435-42.
Association of Physicians of India.API expert consensus document on management of ischemic heart disease.J Assoc Physicians India. 2006;54:469-80.
Kamath A, Shanbhag T, Shenoy S. A Descriptive Study of the Influence of Age and Gender on Drug Utilization in Acute Myocardial Infarction. Journal of Clinical and Diagnostic Research. 2010;(4):2041-46.
National List of Essential Medicines.2015. Available at http://cdsco.nic.in/WriteReadData/NLEM-2015/NLEM,%202015.pdf. Accessed on 12 January 2015.
Report of the core committee for revision of National List of Essential Medicines. November 2015. Available at http://cdsco.nic.in/ WriteReadData/NLEM2015/Recommendations.pdf. Accessed on 12 January 2015.